Who has invested in QL Biopharma?

OrbiMed are named among the investors backing QL Biopharma.

QL Biopharma Funding: $72M Raised, Series (2026)

QL Biopharma funding overview

QL Biopharma is based in Beijing, China. QL Biopharma has raised $72M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series announced in March 2026. The round record for QL Biopharma runs through 2026; nothing later has been disclosed. Investors on record include OrbiMed.

QL Biopharma at a glance

Total raised: $72M
Latest round: Series
Latest round date: March 2026
Headquarters: Beijing, China
Notable investors: OrbiMed

Frequently asked about QL Biopharma funding

How much has QL Biopharma raised?: QL Biopharma has raised $72M in total disclosed funding across the rounds on record.
Who has invested in QL Biopharma?: OrbiMed are named among the investors backing QL Biopharma.
What was the latest QL Biopharma funding round?: The most recent disclosed round is a Series, announced in March 2026.
Where is QL Biopharma based?: QL Biopharma is based in Beijing, China.
When did QL Biopharma last raise?: The last disclosed QL Biopharma round closed in March 2026 at Series.

We update the QL Biopharma record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Beijing and their backers are listed below.

QL Biopharma Funding: $72M Raised, Series (2026)

QL Biopharma funding overview

QL Biopharma at a glance

Frequently asked about QL Biopharma funding

Companies related to QL Biopharma (36)

Browse related funding lists (4)